Immunocore Limited

Immunocore Limited is a UK-based biotechnology company pioneering the world’s first approved T cell receptor therapy. They focus on developing transformative immunomodulating medicines to improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases.